Back
Direxion Daily Gold Miners Bear 2X ETF Vs. Corbus Pharmaceuticals Holdings Industry Stock Comparison
Sell
31
DUST
Direxion Daily Gold Miners Bear 2X ETF
Last Price:
8.24
Seasonality Move:
3.56%
Buy
52
CRBP
Corbus Pharmaceuticals Holdings
Last Price:
37.54
Seasonality Move:
-15.12%
Sell
31
Direxion Daily Gold Miners Bear 2X ETF (DUST)
is a Sell
Is Direxion Daily Gold Miners Bear 2X ETF a Buy, Sell or Hold?
- The current Direxion Daily Gold Miners Bear 2X ETF [DUST] share price is $8.30. The Score for DUST is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
- DUST is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
52
Corbus Pharmaceuticals Holdings (CRBP)
is a Buy
Is Corbus Pharmaceuticals Holdings a Buy, Sell or Hold?
- The current Corbus Pharmaceuticals Holdings [CRBP] share price is $37.03. The Score for CRBP is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
- CRBP is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
DUST Stock Price Chart
What is Direxion Daily Gold Miners Bear 2X ETF's stock price today?
-
The Direxion Daily Gold Miners Bear 2X ETF share price today is $8.30
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and DUST is experiencing buying pressure, which is a positive indicator for future bullish movement.
CRBP Stock Price Chart
What is Corbus Pharmaceuticals Holdings's stock price today?
-
The Corbus Pharmaceuticals Holdings share price today is $37.03
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CRBP is experiencing buying pressure, which is a positive indicator for future bullish movement.
DUST Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.55 | Sell |
Relative Strength Index (14 RSI): | 44.16 | Sell |
Chaikin Money Flow: | 9314439 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (7.82 - 9.1) | Sell |
Bollinger Bands (100): | (9.11 - 12.83) | Sell |
CRBP Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.31 | Sell |
Relative Strength Index (14 RSI): | 49.95 | Sell |
Chaikin Money Flow: | 138813 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (35.78 - 40.1) | Sell |
Bollinger Bands (100): | (10.05 - 38.69) | Buy |
DUST Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 8.13 | Buy |
20-day SMA: | 8.2 | Buy |
50-day SMA: | 10.17 | Sell |
200-day SMA: | 11.85 | Sell |
8-day EMA: | 8.09 | Buy |
20-day EMA: | 8.47 | Sell |
50-day EMA: | 9.62 | Sell |
200-day EMA: | 11.55 | Sell |
CRBP Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 36.31 | Buy |
20-day SMA: | 38.11 | Sell |
50-day SMA: | 36.79 | Buy |
200-day SMA: | 15.23 | Buy |
8-day EMA: | 36.34 | Buy |
20-day EMA: | 37.22 | Sell |
50-day EMA: | 34.42 | Buy |
200-day EMA: | 20.11 | Buy |
Direxion Daily Gold Miners Bear 2X ETF Earnings Growth & DUST Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Corbus Pharmaceuticals Holdings Earnings Growth & CRBP Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.69 per share, a decrease next quarter of $0.00 per share, an increase this year of $5.66 per share, and an increase next year of $0.09 per share.
Direxion Daily Gold Miners Bear 2X ETF Technical Analysis
Apr 17 | Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | ||||||||||
17 | 18 | 19 | 22 | 23 | 24 | 25 | 26 | 29 | 30 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Corbus Pharmaceuticals Holdings Technical Analysis
Apr 17 | Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | ||||||||||
17 | 18 | 19 | 22 | 23 | 24 | 25 | 26 | 29 | 30 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |